جست‌وجوی استاد و پژوهشگر

• Neurophysiology
• Neuropharmacology
• Mitochondrial Biology
• +۵ مورد دیگر

Dr. Andrew Paterson is a Senior Lecturer at the School of Health, Leeds Beckett University, with expertise in neurophysiology and neuropharmacology. He holds a BSc (Hons) in Biomedical Sciences (Pharmacology) from Aberdeen University and a PhD in mitochondrial physiology from the University of Edinburgh's Centre for Integrative Physiology. Current teaching responsibilities: Human Physiology, Medical Pathophysiology, Topics in Neuroscience, and Project modules for Biomedical Sciences undergraduates Teaches Molecular Cell Biology and Physiology for Biomedical Sciences MSc courses Contributes to Medical Science modules for Speech and Language Therapy and Nursing programs His research focuses on formyl peptide receptors (FPRs) in neurological disorders, nano-particle cytotoxicity for cancer applications, and antimicrobial phytochemicals . Recent work explores: Neurite outgrowth mechanisms via FPR agonists Targeted nanoparticle delivery systems Herbal compound cytotoxicity assessment Collaborating with Dr. Margarita Gomez Escalada, he investigates novel antimicrobials for antibiotic resistance solutions. His publications since 2006 address mitochondrial dysfunction in neurodegeneration, receptor signaling, and oxidative stress mechanisms. Contact: A.Paterson@leedsbeckett.ac.uk | Office: Portland 306, City Campus

Martin Kaczochaمشاهده پروفایل

دانشیار

• Lipid Signaling
• Endocannabinoid System
• Inflammatory Pain Mechanisms
• +۴ مورد دیگر

Martin Kaczocha, PhD, is an Associate Professor at Stony Brook University in the Department of Anesthesiology , with affiliations in Biochemistry and Cell Biology . His research focuses on fatty acid binding proteins (FABPs) and their role in endocannabinoid signaling , inflammatory pain , and cancer progression . Research Interests : FABP modulation of endocannabinoid pathways Mechanisms of inflammatory and postsurgical pain Lipid signaling in prostate and hepatocellular cancers Phytocannabinoid interactions with intracellular proteins Scientific Contributions : Developed FABP5 inhibitors for pain and cancer Elucidated FABPs' role in retrograde synaptic signaling Linked FABP5 to taxane-resistant prostate cancer Identified FABP1's impact on THC biotransformation Awards : Young Academic Inventor's Award, Stony Brook NAI Chapter Associate Editor, BMC Anesthesiology Recent Publications : 2024: FABP5's role in tumor immune rewiring (Nature Metabolism) 2024: FABP5 inhibition in osteoarthritis pain (Osteoarthritis Cartilage) 2024: Novel FABP5 inhibitors for neuropathic pain (Journal of Pharmacology) 2023: FABP5 in docetaxel-resistant cancer (Cancers) Students : Livia Schutz (Graduate) Faniya Doswell (Graduate) Mohammad Fauzan (Graduate) Kai Bou (Masters) The Kaczocha lab collaborates with departments including Chemistry , Biochemistry , and Applied Mathematics , with funding from NIDA , NIMH , and NCI . Current projects explore FABP5's role in neuropathic pain , prostate cancer metastasis , and phytocannabinoid mechanisms .

• Computational Neuroscience
• Neurophysiology
• Synaptic Plasticity
• +۳ مورد دیگر

Stéphane Genet is an Associate Professor affiliated with Sorbonne University's RPI-Bio Team, focusing on computational neuroscience and neurophysiology. His work bridges mathematical modeling with experimental approaches to study neural dynamics and plasticity. Academic Rank: Associate Professor Department: RPI-Bio Team Genet’s research explores: Computational neuroscience mechanisms Endocannabinoid signaling in synaptic plasticity Mathematical modeling of neuronal dynamics Biophysical properties of cerebellar neurons Non-linear systems in agent perception Cerebellar circuitry and Purkinje cell functions His publications since 2010 highlight interdisciplinary work in neuroscience, physiology, and robotics, with a focus on spike-timing dependent plasticity and dendritic signaling. Recent outputs (2021) emphasize ionic mechanisms in deep cerebellar nuclei.

Justin Kimمشاهده پروفایل

دانشیار

• Organic Chemistry
• Chemical Biology
• Bioorthogonal Chemistry
• +۵ مورد دیگر

Justin Kim serves as an Associate Professor at Georgia Institute of Technology, leading a research program at the intersection of organic chemistry, chemical biology, and materials science with significant applications in drug discovery and biomaterials development. His academic credentials include: Ph.D. in Organic Chemistry from Massachusetts Institute of Technology (2013) A.M. in Chemistry and A.B. in Chemistry and Physics from Harvard University (2007) Prof. Kim's research employs a bottom-up molecular approach to address challenges in organic synthesis and biological systems. The Kim Lab specializes in bioorthogonal reaction development , chemoproteomics-based target discovery , and functionally adaptive biomaterials , with particular emphasis on lipid biochemistry and endocannabinoid systems. Their work bridges fundamental chemical reactivity with therapeutic applications, focusing on inflammation modulation, neurodegenerative disorders, and metabolic disease mechanisms. Analysis of recent publications reveals a strong thematic focus on lipid mediators in disease pathology , particularly examining how viral infections (especially influenza) impact neurological conditions like multiple sclerosis through alterations in myelin lipidomes and oligodendrocyte function. A secondary research thread investigates postprandial glucose regulation using natural compounds and engineered biomaterials. Major recognitions include: NSF CAREER Award (2023) for pioneering contributions to chemical biology Thieme Chemistry Journal Award (2021) for innovative synthetic methodologies NIH Director’s New Innovator Award (2018) supporting high-risk/high-reward research in endocannabinoid pharmacology The Kim Lab operates with substantial grant support including the NIH New Innovator Award, enabling advanced instrumentation for lipidomics and molecular imaging. Current collaborations span immunology, neuroscience, and metabolic disease research, with emphasis on translating chemical tools into diagnostic and therapeutic platforms. While specific advisees aren't listed in source materials, the lab structure indicates mentorship of graduate researchers in chemical biology and organic synthesis. The research group maintains active investigation of omega-3 endocannabinoids, bioorthogonal probes for target identification, and glucose-responsive biomaterials, with recent expansion into viral-neurological interactions and metabolic inflammation pathways.

Eman Solimanمشاهده پروفایل

استادیار

• Neuroimmunology
• Traumatic Brain Injury
• Efferocytosis
• +۵ مورد دیگر

Eman Soliman is an Assistant Professor at the Brody School of Medicine , East Carolina University, specializing in Pharmacology & Toxicology . Her research focuses on neuroimmune interactions in traumatic brain injury recovery, with a particular emphasis on efferocytosis, microglial and macrophage function, and neuroinflammatory signaling pathways. B.S. in Pharmaceutical Sciences, Zagazig University, Egypt M.Sc. in Pharmacology, Zagazig University, Egypt Ph.D. in Pharmacology and Toxicology, East Carolina University Post-doctoral Fellowships in Immunology (East Carolina University) and Neuroimmunology (Virginia Tech) Her work employs transgenic mouse models, bone marrow chimeras, and advanced 3D imaging to investigate spatial, temporal, and sex-specific regulation of inflammation resolution in the brain. Key themes include the role of EphA4 signaling in efferocytosis, microglia-macrophage communication, and neuroprotective mechanisms after injury. Recent publications highlight her contributions to understanding endothelial-astrocyte interactions, Tie2/Akap12 signaling, and NLRX1-cGAS-STING pathways in neuroinflammation. Articles also explore ABCG1 deficiency, PPARγ roles in granulomatous inflammation, and translational applications of cannabinoids in cancer and neuroinflammatory diseases. The Soliman Lab collaborates with researchers on topics like EphA4 deletion, prostamide therapies, and mitochondrial dysfunction in chronic diseases. Current projects aim to identify targetable mechanisms for enhancing neuroprotection and functional recovery following brain injury.

• Neural control of circulation
• Estrogen modulation of cardiac function
• Cardiovascular effects of alcohol
• +۵ مورد دیگر

Abdel A. Abdel-Rahman, PhD, FAHA is a Distinguished Professor and Vice Chair in the Department of Pharmacology and Toxicology at East Carolina University's Brody School of Medicine. He joined ECU in March 1985 as an assistant professor, was promoted to associate professor with tenure in 1989, and to full professor in 1994. He has served as Vice Chair of the department since 2006 and has received ECU's Lifetime Achievement Award and Distinguished Professorship in 2000, along with Brody's Master Educator Award. Dr. Abdel-Rahman's research focuses on neural control of circulation, estrogen modulation of cardiac function in health and disease, diabetes and cardiovascular complications, and the cardiovascular effects of alcohol and cannabinoids. His work particularly examines sex differences in cardiovascular responses, with recent emphasis on circadian rhythm proteins like PER2, connexin-43 signaling pathways, and cannabinoid receptor mechanisms in cardiac function regulation. His publications from 2020-2025 demonstrate consistent productivity in high-impact pharmacology and cardiovascular journals. He has been continuously funded by the NIH since 1988 through 2023, with two overlapping R01 grants totaling 40 years of funding exceeding $12 million. His most recent research examines how estrogen replacement restores period 2-mediated inhibition of ferroptosis to mitigate cardiac dysfunction in estrogen-deficient models, and how ethanol induces cardiopulmonary inflammation leading to hypertension. ECU's Lifetime Achievement Award and Distinguished Professorship (2000) Brody's Master Educator Award Fellow of the American Heart Association (FAHA) Teavel Award from American Heart Association (2023) Volkman Award from ECU Brody School of Medicine (2022) RCAW best graduate student poster Award (2022) Dr. Abdel-Rahman has trained 16 graduate students and 17 postdoctoral scholars, with several receiving awards for their research. He serves on editorial boards of multiple journals including Frontiers in Pharmacology and has organized research topics on cardiorenal dysregulation. His extensive grant funding and service on NIH study sections since 2016 demonstrates his standing in the cardiovascular research community. His work bridges basic science with clinical implications, particularly regarding sex differences in cardiovascular responses to alcohol, diabetes, and other stressors.

Shana M Augustinمشاهده پروفایل

استادیار

• Neuroscience
• Pharmacology
• Addiction
• +۵ مورد دیگر

Shana M Augustin, PhD is a tenure-track Assistant Professor in the Department of Pharmacology at Northwestern University's Feinberg School of Medicine, holding a secondary appointment in Psychiatry and Behavioral Sciences. She serves as Principal Investigator at the Center for Psychiatric Neuroscience. Her educational background includes a BS in Biology from the University of the Virgin Islands (2006), PhD in Neurobiology from the University of Chicago (2013), and postdoctoral training at Emory University and the National Institute on Alcohol Abuse and Alcoholism (NIAAA) at NIH. Dr. Augustin's research focuses on molecular mechanisms of synaptic transmission within cortico-basal ganglia circuits, particularly investigating how GPCR-mediated neuromodulation affects decision-making and reward behaviors. Her lab employs brain slice electrophysiology optogenetics/chemogenetics 2-photon imaging in vivo fiber photometry mouse behavioral models to study disruptions in neural circuits underlying substance use disorders and neurodegeneration. Her recent publications reveal key insights into ethanol's impact on endocannabinoid signaling , dopamine dynamics in striatal pathways , and cannabinoid-induced synaptic adaptations , establishing critical molecular targets for therapeutic interventions. Dr. Augustin leads the Augustin Lab at the Searle Building, developing innovative approaches to treat alcohol use disorders and related neurological conditions through precise modulation of neuromodulatory systems.

• Neuropharmacology
• Traumatic Brain Injury
• Neuropathic Pain
• +۳ مورد دیگر

Yumin Zhang MD, PhD is a Professor in the Department of Anatomy, Physiology and Genetics at the Uniformed Services University of the Health Sciences School of Medicine in Bethesda, Maryland. Her primary research focuses on endocannabinoid signaling modulation in neurological disorders. Her educational background includes an M.D. from Binzhou Medical School in Shandong, China, a Ph.D. in Biochemistry from Hebrew University in Jerusalem, Israel, and postdoctoral training in Neurology at Children’s Hospital/Harvard Medical School. Dr. Zhang's research centers on neuropharmacological interventions for traumatic brain injury, neuropathic pain, and multiple sclerosis . Her work investigates how endocannabinoid and eicosanoid pathways regulate neuroinflammation and neural repair. Key methodologies include in vivo disease models, microglial cell culture, RNA sequencing, and enzyme pharmacology targeting FAAH and ABHD6. Analysis of her recent publications reveals consistent focus on cannabinoid receptor mechanisms and lipid mediator pathways across neurological conditions. Her group demonstrates particular expertise in developing enzyme inhibitors that modulate neuroimmune responses without classical cannabinoid side effects. Her research group maintains active collaborations with military medical institutions through the Uniformed Services University. Current work emphasizes translating endocannabinoid modulation into therapies for combat-related neurological injuries and chronic pain conditions.

Joshua Havelinمشاهده پروفایل

استادیار

• Neuroscience
• Pain Research
• Biochemistry
• +۴ مورد دیگر

Joshua Havelin is an Assistant Professor of Chemistry at Thomas College, holding a Ph.D. in Biomedical Sciences (Neuroscience) from the University of Maine (2019) and a B.S. in Biochemistry and Medical Biology with honors from the University of New England (2011). His academic background includes: Ph.D. in Biomedical Sciences (Neuroscience focus), University of Maine, 2019 B.S. in Biochemistry and Medical Biology (with honors), University of New England, 2011 Dr. Havelin's research investigates chronic pain mechanisms in cancer-induced bone pain and osteoarthritis, focusing on sensory neuron subsets that drive drug-resistant phenotypes. Using transgenic and pharmacological tools, his work identifies distinct pathways for ongoing pain versus movement-evoked breakthrough pain, aiming to discover novel therapeutic targets for poorly managed chronic conditions. His 2013-2019 publications reveal consistent exploration of pain modulation mechanisms, particularly how kappa opioid receptors, cannabinoid 2 agonists, and specific nociceptor populations (e.g., IB4-binding neurons) influence cancer and osteoarthritis pain. Key trends include dissecting neuroimmune interactions in inflammatory pain and validating exercise interventions for joint pain. Scientific recognitions include: Nominated for Student Mentorship and Advising Award (Spring 2022) Society for Neuroscience Trainee Professional Development Award (Fall 2017) 1st place in University of New England Spring Undergraduate Research Symposium (Spring 2010) University of New England Summer Stipend recipient (Summer 2009) He actively mentors students as Chemistry Club Advisor (2023-2024) and Pre-Health Professions Advisory Committee member (2022), emphasizing experiential learning. Community engagement includes judging the Maine State Science Fair (2015-2022) and Maine Research Symposium (2022), while his interdisciplinary approach bridges biochemistry with home brewing and cooking hobbies. Dr. Havelin collaborates with researchers like Tamara King on pain mechanisms, leveraging rodent models to study neuronal contributions to cancer pain. His current role at Thomas College involves developing research infrastructure for undergraduate pain neuroscience projects, though specific lab details remain unstated in available materials.

• Pharmacology
• Neuropharmacology
• Inflammation
• +۴ مورد دیگر

Özgür GÜNDÜZ is a Professor at Trakya University's Medical Faculty, Department of Medical Pharmacology. He earned his Doctoral Degree (2010), Bachelor's Degree (2004), and high school diploma (1997). His academic progression includes promotion to Associate Professor in 2017 and Professor in 2024. Research interests center on neuropharmacology, inflammation, and cannabinoid systems. Key areas include: Ischemic conditioning (pre/post) for organ protection Cannabinoid and endocannabinoid pathways in pain/itch modulation TRPV1 receptors in neurological disorders Hydrogen sulfide therapeutics Publications emphasize translational models of pain, dermatitis, and organ injury, with consistent focus on receptor-level mechanisms and novel analgesics. Recent works explore remote ischemic conditioning and cannabinoid interactions. Awards: 2018 Dogsan Science Award for experimental research on ischemic preconditioning in skin flaps Projects & Advising: Leads multiple grants including studies on diabetic neuropathy, endocannabinoids in stress models, and fasudil effects in contact hypersensitivity. Advises Master's students on endocannabinoid systems. Professional Roles: Editorial Board Member for Balkan Medical Journal (2018–2024) and member of the Local Animal Ethics Committee.

• Endocannabinoid System Pharmacology
• Neuropsychopharmacology
• Pain Management Mechanisms
• +۲ مورد دیگر

Ruhan Deniz TOPUZ serves as an Assistant Professor in the Department of Medical Pharmacology at Trakya University Faculty of Medicine, specializing in neuropsychopharmacology and endocannabinoid system research. With a medical degree (2005) and PhD in Medical Pharmacology (2015) from the same institution, their work bridges clinical medicine and molecular neuroscience. Education includes: Bachelor of Medicine, Trakya University Faculty of Medicine (2005) Doctorate in Medical Pharmacology, Trakya University (2015) Research focuses on endocannabinoid signaling in stress responses, pain mechanisms, and cognitive disorders. Key interests include TRPV1 receptor interactions with analgesics, neuroinflammation in psychiatric conditions, and epigenetic regulation of memory. Recent work explores serum biomarkers for bipolar disorder and novel interventions for autism spectrum disorders using natural compounds. Analysis of 15 most recent publications reveals strong emphasis on: Endocannabinoid system modulation in psychiatric and neurological conditions Ischemic conditioning techniques for pain and tissue repair Natural compounds (fucoxanthin, ginsenosides) as neuroprotectants Molecular mechanisms linking stress to cognitive impairment As primary supervisor for multiple Master's theses, TOPUZ mentors research on fear conditioning, autism models, and neurotensin signaling. Current projects investigate remote ischemic conditioning for neuropathic pain and serum biomarkers in stress models. Active in ethical oversight as Clinical Research Ethics Committee member since 2023, with h-index 6 reflecting impactful contributions to pharmacological neuroscience.

• Adaptive Immunology
• Immunotoxicology
• B Cell Biology
• +۳ مورد دیگر

Lance K. Blevins is an Assistant Professor at the Institute for Integrative Toxicology , Michigan State University, with joint appointments in the Food Safety and Toxicology department. He holds a PhD in Molecular and Cellular Biosciences (Immunology) from Wake Forest University and a Biology BA from University of North Carolina at Chapel Hill. Education: PhD, Wake Forest University (2016) - Molecular & Cellular Biosciences (Immunology) BA, University of North Carolina at Chapel Hill (2007) - Biology Dr. Blevins' research centers on adaptive immunology with particular emphasis on: CD5+ Innate-Like B Cell vulnerability to environmental toxins Aryl Hydrocarbon Receptor (AHR) activation mechanisms TCDD (Dioxin) immunotoxicity pathways Xenobiotic-Mediated IgM response suppression Molecular Mechanisms of toxicant-induced immune dysfunction His work reveals CD5+ B cells exhibit heightened AHR expression leading to impaired immunoglobulin M production following dioxin exposure. Current projects aim to characterize understudied immune cell populations and elucidate AHR signaling networks in human immunotoxicology. Through collaborative studies with NE Kaminski's team, Dr. Blevins investigates: Cannabinoid receptor modulation of neuroinflammatory markers Complement system activation in viral pathogenesis TSPO localization in HIV+ immune dysregulation Lactoferrin safety via GLP immunotoxicity assays Streptococcus pneumoniae immune evasion mechanisms Proteomic profiling of dioxin exposure effects His methodological approach combines human primary cell cultures , rodent models , and multi-omics analysis to bridge environmental toxicology with immune system dysfunction .

• Neurotoxicology
• Neuroregeneration
• Olfactory System Research
• +۳ مورد دیگر

Colleen Cosgrove Hegg is an Associate Professor in the Department of Pharmacology and Toxicology at Michigan State University, with a joint appointment in the Neuroscience Program. Her research focuses on purinergic signaling in olfactory neuroregeneration and environmental toxicant effects on the olfactory system. B.A. in Chemistry, Kalamazoo College (1990) Ph.D. in Environmental Toxicology, University of Wisconsin (1996) Dr. Hegg investigates how endogenous ATP functions as a neurotrophic factor following pollutant exposure in the olfactory epithelium. Her work spans cellular toxicity mechanisms in the nervous system, glial cell function, and purinergic receptor dynamics in neuroregeneration. Key areas include airborne toxicant impacts, olfactory stem cell aging, and neuroinflammatory responses. Her publications from 2000–2024 address ATP signaling, cannabinoid modulation, and mycotoxin-induced neuronal apoptosis, primarily in Neuroscience , J Neurophysiol , and Toxicol Sci . Trends highlight environmental neurotoxicology, sensory system repair, and receptor-mediated cellular responses. Current affiliations include: Department of Pharmacology and Toxicology, MSU Neuroscience Program, MSU

Quentin Pittmanمشاهده پروفایل

استاد مدعو

• Neuroscience
• Neuroimmunology
• Inflammation
• +۵ مورد دیگر

Dr. Quentin Pittman is an Adjunct Professor in the Department of Physiology and Pharmacology at the Cumming School of Medicine, University of Calgary. He also holds positions as a Child Health & Wellness Researcher at the Alberta Children's Hospital Research Institute, Full Member of the Hotchkiss Brain Institute, Deputy Chair in the Department of Physiology and Pharmacology, and Full Member of the Mathison Centre for Mental Health Research and Education. Dr. Pittman's educational background includes: B.A. in Biological Sciences, University of Lethbridge, 1972 Doctor of Philosophy in Physiology, University of Calgary, 1976 Dr. Pittman's research focuses on neuroimmune-endocrine interactions, particularly how inflammation affects brain function and behavior. His work spans four major areas: the effects of inflammation on the brain leading to behavioral co-morbidities; cellular actions of peptides, mediators and neurotransmitters; early life programming of the brain by inflammation; and febrile seizures. His laboratory employs approaches ranging from whole animal models studying physiology and behavior to cellular studies examining morphological, molecular, electrophysiological and synaptic properties. He collaborates extensively with researchers including Keith Sharkey, Mark Swain, Simon Hirota and Matt Hill to explore how chronic peripheral inflammation in animal models of colitis, arthritis and liver disease cause changes in the brain that may underlie psychiatric co-morbidity. Analysis of Dr. Pittman's recent publications (2019-2022) reveals a strong focus on the gut-brain axis, neuroinflammation, and microglial function. His work increasingly examines how the microbiome influences brain function and behavior, particularly in inflammatory conditions. There's also a significant emphasis on the endocannabinoid system's role in modulating neural circuits affected by inflammation and stress. His research bridges basic neuroscience with clinical relevance, particularly for understanding psychiatric comorbidities in inflammatory diseases and neurological conditions like epilepsy. Dr. Pittman has received numerous prestigious awards throughout his career: Fellow of the Royal Society of Canada (2010) Fellow of the Canadian Academy of Health Sciences (2016) Fellow of the American Physiological Society (2019) Distinguished Member of the International Regulatory Peptide Society (2021) Multiple teaching awards including Golden Apple Award (2008) and Honor Roll for Great Teaching (2014) University Professor designation at the University of Calgary (2006) Dr. Pittman has maintained continuous research program support from the MRC/CIHR and other agencies for nearly 40 years. His collaborative approach is evident in his extensive network of research partnerships across multiple institutes including the Hotchkiss Brain Institute and Alberta Children's Hospital Research Institute. He has held numerous leadership positions within these organizations and has served on committees for national and international scientific societies. His laboratory has produced significant findings on how early life inflammation programs long-term brain function and vulnerability to neurological conditions. Dr. Pittman's laboratory work spans multiple facilities including the Health Sciences Centre at the University of Calgary. His research team employs diverse methodologies from whole animal behavioral studies to sophisticated cellular and molecular techniques including patch clamp electrophysiology. His work on neuroimmune interactions has positioned his laboratory at the forefront of understanding how peripheral inflammation communicates with the central nervous system to influence behavior and neural function.